Abbott Completes Separation of Research-Based Pharmaceuticals Business
Monday, January 07, 2013
Set to deliver industry-leading growth, expanding margins and strong cash flow.
4SC AG Further Strengthens Supervisory Board
Monday, December 31, 2012
Appointment of Dr Irina Antonijevic and Mr Klaus Kühn.
Nuvo Research Announces New Listing of Synera® Patent in FDA Orange Book
Thursday, December 27, 2012
The Synera Patent expiry date is July 7, 2020.
Karus Therapeutics Announces Collaboration with Babraham Institute
Tuesday, December 18, 2012
Collaboration to explore PI3 kinase inhibitors in the treatment of inflammatory diseases.
Study Paves way to Design Drugs Aimed at Multiple Protein Targets at Once
Thursday, December 13, 2012
Pharmaceutical chemists had suggested that the objective of a drug hitting multiple targets simultaneously is impossible and unlikely to succeed. This study shows how to efficiently and effectively make designer drugs that can do that.
MRC Delivering on the Life Sciences Strategy, One Year On
Tuesday, December 11, 2012
The Medical Research Council has made significant progress in implementing the measures outlined in last year’s Strategy for UK Life Sciences, according to a progress update published by the Government.
Cancer Survival Rates will be Boosted by Drug Development
Monday, December 10, 2012
Bristol-Myers Squib’s research chief discusses pharmaceutical innovations at UCSF cancer center showcase.
Anagnostics Enters Sales Cooperation with Analis S.A.
Monday, December 10, 2012
Company enters cooperation for Belgium and Luxembourg.
Covance’s Shanghai, China Facility Receives SFDA GLP Certification
Wednesday, December 05, 2012
SFDA certification validates Covance's consistent global quality.
|
|
|
|
|
|
